Key result
The rs2074192 (ACE2), rs1799752 (ACE1), and rs699 (AGT) polymorphisms were associated with symptomatic COVID-19, with the rs2074192 T/T genotype in males strongly predicting symptomatic status.
Why the study?
RAAS components are key factors for SARS-CoV-2 cellular entry and pathogenesis, motivating the assessment of RAAS gene polymorphisms between symptomatic and asymptomatic patients.
Do RAAS polymorphisms (ACE1, ACE2, AGT, AGTR1) predict symptomatic versus asymptomatic clinical outcomes in patients with SARS-CoV-2 infection?
Observational (n=104)
No
Do RAAS polymorphisms (ACE1, ACE2, AGT, AGTR1) predict symptomatic versus asymptomatic clinical outcomes in patients with SARS-CoV-2 infection?
Answers are grounded in this paper and cite their sources.
Specific RAAS polymorphisms (rs2074192, rs1799752, and rs699) may predict the clinical severity of SARS-CoV-2 infection.
Introduction: The renin–angiotensin–aldosterone system (RAAS), a metabolic cascade regulating pressure and circulating blood volume, has been considered the main system involved in the pathogenesis of severe lung injury and organs decline in COVID-19 patients. The angiotensin I-converting enzyme ( ACE1 ), angiotensin-converting enzyme 2 ( ACE2 ), angiotensinogen (AGT) and receptors angiotensin II receptor type 1 ( AGTR1 ) are key factors for SARS-CoV-2 entering in the cells, sodium and water retention with an increase blood pressure, promotion of fibrotic and inflammatory phenomena resulting in a cytokine storm. Methods: In this pilot study, the frequencies of six polymorphisms in the ACE1, ACE2, AGT and AGTR1 genes were analysed in symptomatic patients affected by COVID-19 and compared with the results obtained from asymptomatic subjects. Results: Thus, we have identified that rs2074192 ( ACE2 ), rs1799752 ( ACE1 ) and rs699 ( AGT ) SNPs could potentially be a valuable tool for predicting the clinical outcome of SARS-CoV-2 infected patients. A genetic predisposition may be prospected for severe internal organ damages and poor prognosis in patients with COVID-19 disease, as observed in symptomatic vs asymptomatic. Conclusion: This study provides evidence that analysis of RAAS polymorphisms could be considered the key point in understanding and predicting the SARS-CoV-2 course infection.
No takes yet. Share an insight, caveat, or question.
Cafiero et al. (2021) conducted an observational in SARS-CoV-2 infection (COVID-19) (n=104). RAAS polymorphisms (ACE1, ACE2, AGT, AGTR1) vs. Reference genotypes / Asymptomatic infection was evaluated on rs2074192 T/T genotype frequency in symptomatic vs asymptomatic males (codominant model) (OR 15.79, 95% CI 1.90-131.47, p=0.0019). The rs2074192 (ACE2), rs1799752 (ACE1), and rs699 (AGT) polymorphisms were associated with symptomatic COVID-19, with the rs2074192 T/T genotype in males strongly predicting symptomatic status.
Synapse has enriched 10 related papers. Consider them for comparative context: